nm23 in ovarian cancer: Correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters

Journal of Clinical Oncology

Volumn 14, Issue 2, 1996, Pages 334-342

  Scambia, G ^a   Ferrandina, G ^a   Marone, M ^a   Benedetti Panici, P ^a   Giannitelli, C ^a   Piantelli, M ^a   Leone, A ^a   Mancuso, S ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NM23 H2 PROTEIN; NM23 PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030020321     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.2.334     Document Type: Article

References (40)

1. Steeg PS, Bevilacqua G, Kopper I, et al: Evidence for a novel gene associated with a low tumor metastatic potential. J Natl Cancer Inst 80:200-204, 1988
2. Steeg PS, Bevilacqua G, Pozzatti R, et al: Altered expression of nm23, a gene associated with low tumor metastatic potential during adenovirus 2 ElA inhibition of experimental metastasis. Cancer Res 48:6550-6554, 1988
3. Kantor JD, McCormick B, Steeg PS, et al: Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 53:1971-1973, 1993
4. Leone A, Flatow U, Richter King C, et al: Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65:25-35, 1991
5. Leone A, Flatow U, VanHoutte K, et al: Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8:2325-2333, 1993
6. Stahl JA, Leone A, Rosengard AM, et al: Identification of a second human nm23 gene, nm23-H2. Cancer Res 51:445-449, 1991
7. Backer JM, Mendola CE, Kovesdi I, et al: Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes nm23-1 and nm23-2. Oncogene 8:497-502, 1993
8. Gilees AM, Presecan E, Vonica A, et al: Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of hexameric enzyme. J Biol Chem 266:8784-8789, 1991
9. Kimura N, Shimada N, Nomura K, et al: Isolation and characterization of cDNA clone encoding rat nucleoside diphosphate kinase. J Biol Chem 265:15744-15749, 1990
10. Wallet V, Mutzel R, Troll H, et al: Dictyostelium nucleoside diphosphate kinase highly homologous to nm23 and awd proteins involved in mammalian tumour metastasis and development. J Natl Cancer Inst 82:1199-1202, 1990
11. Rosengard AM, Krutzsch HC, Shearn A, et al: Reduced nm23/awd protein in tumor metastasis and aberrant Drosophila development. Nature 342:177-180, 1989
12. Nickerson JA, Wells WW: The microtubule-associated nucleoside diphosphate kinase. J Biol Chem 259:1297-1304, 1984
13. Ohtsuki K, Ikeuchi T, Yokoyama M: Characterization of nucleoside-diphosphate kinase-associated guanine nucleotide binding proteins from HeLa S3 cells. Biochim Biophys Acta 882:322-330, 1986
14. Walton G, Gill G: Nucleotide regulation of an eukaryotic protein synthesis initiation complex. Biochim Biophys Acta 300:231-245, 1975
15. MacDonald JN, De La Rosa A, Benedict MA, et al: A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268:25780-25789, 1993
16. Postel EH, Berberich SJ, Flint SJ, et al: Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261:478-480, 1993
17. Bevilacqua G, Sobel ME, Liotta LA, et al: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49:5185-5190, 1989
18. Tokunaga Y, Urano T, Furukawa K, et al: Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer 55:66-71, 1993
19. Nakayama T, Ohtsuru A, Nakao K, et al: Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 84:1349-1354, 1992
20. Konishi N, Nakaoka S, Tsuzuki T, et al: Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma. Jpn J Cancer Res 84:1050-1054, 1993
21. Nakayama H, Yasui W, Yokozaki H, et al: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 84:184-190, 1993
22. Florenes VA, Aamdal S, Myklebost O, et al: Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression. Cancer Res 52:6088-6091, 1992
23. Leone A, Seeger RC, Hong CM, et al: Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8:855-865, 1993
24. Nakamori S, Ishikawa O, Ohigashi H, et al: Clinicopathological features and prognostic significance of nucleoside diphosphate kinase/nm23 gene product in human pancreatic exocrine neoplasms. Int J Pancreatol 14:125-134, 1993
25. Higashiyama M, Doi O, Yokouchi H, et al: Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value. Br J Cancer 66:533-536, 1992
26. Sawan A, Lascu I, Veron M, et al: NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: An immunohistochemical study. J Pathol 172:27-34, 1994
27. Mandai M, Konishi I, Koshiyama M, et al: Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: Correlation with clinicopathology, EGFR c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res 54:1825-1830, 1994
28. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment, no. 48, Geneva, Switzerland, WHO, 1979, pp 16-21
29. Chomczynski P, Sacchi N: Single step method of RNA isolation by guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
30. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1982
31. Meiners S, Marone M, Rittenhouse JL, et al: Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev Biol 160:480-493, 1993
32. Scambia G, Catozzi L, Benedetti Panici P, et al: Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: Correlation with histopathological features and receptors for estrogen, progesterone, and epidermal growth factor. Am J Obstet Gynecol 168:71-77, 1993
33. EORTC Breast Cancer Cooperative Group: Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16:1513-1515, 1980
34. Scambia G, Benedetti Panici P, Battaglia F, et al: Significance of epidermal growth factor receptor in advanced ovarian cancer. J Clin Oncol 10:529-535, 1992
35. Mantel N: Evaluation of survival data and two new rank order statistics arising its consideration. Cancer Chemother Rep 50:163-170, 1966
36. Cox DR: Regression models and life tables. J R Stat Soc 34:197-220, 1972
37. Myeroff LL, Markowitz SD: Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst 85:47-52, 1993
38. Royds JA, Cross SS, Silcocks PB, et al: nm23 antimetastatic gene product expression in colorectal carcinoma. J Pathol 172:261-266, 1994
39. Slotman BJ: Rationale for the Use of Endocrine Therapy in Ovarian Cancer. Vrije University, Amsterdam, The Netherlands, Thesis Publisher, 1990
40. Egan SG, McClarty GA, Jarolim L, et al: Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10 T1/2 and NIH 3T3 cells. Mol Cell Biol 7:830-837, 1987